Upadacitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis: analysis of the Heads Up phase III trial

被引：0
|
作者：
Blauvelt, A. [1 ]
Teixeira, H. D. [2 ]
Simpson, E. L. [3 ]
Costanzo, A. [4 ,5 ]
De Bruin-Weller, M. [6 ]
Barbarot, S. [7 ]
Prajapati, V. H. [8 ,9 ,10 ,11 ,12 ,13 ]
Lio, P. [14 ,15 ]
Hu, X. [2 ]
Wu, T. [2 ]
Liu, J. [2 ]
Ladizinski, B. [2 ]
Chu, A. D. [2 ]
Eyerich, K. [16 ,17 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[4] Humanitas Univ, Dept Biomed Sci, Dermatol Unit, Pieve Emanuele, Italy
[5] IRCCS, Humanitas Clin & Res Ctr, Rozzano, Italy
[6] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands
[7] Nantes Univ, CHU Nantes, Dept Dermatol, Nantes, France
[8] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada
[9] Univ Calgary, Dept Pediat, Div Community Pediat, Calgary, AB, Canada
[10] Univ Calgary, Dept Pediat, Div Pediat Rheumatol, Calgary, AB, Canada
[11] Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[12] Dermatol Res Inst, Calgary, AB, Canada
[13] Prob Med Res, Calgary, AB, Canada
[14] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
[15] Med Dermatol Associates Chicago, Chicago, IL USA
[16] Karolinska Inst, Stockholm, Sweden
[17] Karolinska Univ Hosp, Stockholm, Sweden
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
489
引用
收藏
页码：E123 / E123
页数：1
相关论文
共 50 条
  • [41] Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis
    Armstrong, April W.
    Hong, H. Chih-Ho
    Calimlim, Brian M.
    Buessing, Marric G.
    Crowell, Marjorie M.
    Silverberg, Jonathan I.
    DERMATOLOGY AND THERAPY, 2024, 14 (09) : 2457 - 2465
  • [42] DISCONTINUATION OF TOPICAL CORTICOSTEROIDS IN UPADACITINIB-TREATED PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS FROM THE AD UP PHASE 3 TRIAL
    Reich, Kristian
    Boguniewicz, Mark
    Kabashima, Kenji
    Barbarot, Sebastien
    Girolomoni, Giampiero
    Mendes-Bastos, Pedro
    Gamelli, Amy
    Liu, Yingyi
    Teixeira, Henrique
    Armstrong, April
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 61 - 61
  • [43] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
    Meher, Bikash R.
    Mishra, Archana
    Behera, Biswanath
    Ponnusamy, Subashri
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [44] Network meta-analysis on the efficacy and safety of upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis
    Qiu, Mei
    Duan, Xue-Yan
    Yin, Dao-Gen
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (01) : E24 - E26
  • [45] Dupilumab prevents flares in adults with moderate-to-severe atopic dermatitis in a 52-week, randomized, controlled, phase 3 trial
    Merola, J. F.
    Sidbury, R.
    Wollenberg, A.
    Chen, Z.
    Zhang, A.
    Shumel, B.
    Rossi, A. B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S53 - S53
  • [46] Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial
    Sher, Lawrence
    Soong, Weily
    Mina-Osorio, Paola
    Prescilla, Randy
    Chen, Zhen
    Bansal, Ashish
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB191 - AB191
  • [47] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    Marjolein S. de Bruin-Weller
    Esther Serra-Baldrich
    Sebastien Barbarot
    Susanne Grond
    Christopher Schuster
    Helmut Petto
    Jean-Philippe Capron
    Afaf Raibouaa
    Thomas Werfel
    Dermatology and Therapy, 2022, 12 : 1481 - 1491
  • [48] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    de Bruin-Weller, Marjolein S.
    Serra-Baldrich, Esther
    Barbarot, Sebastien
    Grond, Susanne
    Schuster, Christopher
    Petto, Helmut
    Capron, Jean-Philippe
    Raibouaa, Afaf
    Werfel, Thomas
    DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1481 - 1491
  • [49] EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis
    Agache, Ioana
    Akdis, Cezmi
    Akdis, Mubeccel
    Brockow, Knut
    Chivato, Tomas
    del Giacco, Stefano
    Eiwegger, Thomas
    Eyerich, Kilian
    Gimenez-Arnau, Ana
    Gutermuth, Jan
    Guttman-Yassky, Emma
    Maurer, Marcus
    Ogg, Graham
    Ong, Peck Y.
    O'Mahony, Liam
    Schwarze, Juergen
    Warner, Amena
    Werfel, Thomas
    Palomares, Oscar
    Jutel, Marek
    ALLERGY, 2021, 76 (04) : 988 - 1009
  • [50] Dupilumab Improves Sleep in Adults with Moderate-to-Severe Atopic Dermatitis over 24 Weeks
    Merola, Joseph F.
    Chiou, Albert S.
    During, Emmanuel
    Foley, Peter
    Ardeleanu, Marius
    Wu, Jiangming
    Ozturk, Zafer
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB150 - AB150
12345